Beware Marketing Cannabidiol Products: FDA Is Watching
Law360, New York (December 5, 2017, 2:18 PM EST) -- The U.S. Food and Drug Administration recently issued warning letters to four companies — Stanley Brothers Social Enterprises LLC, Greenroads Health, Natural Alchemist, and That’s Natural! Marketing and Consulting — that market edibles, oils, tinctures, capsules and topical creams containing cannabidiol (CBD), a nonpsychotropic cannabinoid found in cannabis.
Although the violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) cited in these letters are nothing new (the FDA sent similar letters to more than a dozen CBD companies in 2015 and 2016), they should serve as a reminder to companies marketing and selling these products that the FDA is...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!